Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries G1 Therapeutics Inc (NQ: GTHX ) 2.570 +0.060 (+2.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about G1 Therapeutics Inc < Previous 1 2 3 4 5 Next > Evercore ISI Is Warming Up to NextEra Energy (NEE) Stock February 13, 2024 NextEra Energy stock is on the move Tuesday after Evercore ISI initiated coverage of NEE shares with a bull rating and price target. Via InvestorPlace UBS Just Upped Its Nvidia (NVDA) Stock Price Target February 13, 2024 Nvidia stock is a hot topic among NVDA traders on Tuesday after the company's shares got a new $850 price target from UBS analysts. Via InvestorPlace Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket February 13, 2024 Shares of ZoomInfo Technologies Inc. (NASDAQ: ZI) rose sharply in today’s pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Via Benzinga Why Is Polished.com (POL) Stock Down 33% Today? February 13, 2024 Polished.com stock is sliding lower on Tuesday as investors in POL react to the company missing a debt payment and other dangers. Via InvestorPlace Earnings Preview For G1 Therapeutics October 31, 2023 Via Benzinga Analyst Ratings for G1 Therapeutics October 06, 2023 Via Benzinga Analyst Ratings for G1 Therapeutics August 03, 2023 Via Benzinga Why Is G1 Therapeutics (GTHX) Stock Down 45% Today? February 13, 2024 G1 Therapeutics stock is down on Tuesday after the company provided GTHX investors with an update on a Phase 3 clinical trial. Via InvestorPlace ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday February 13, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday February 13, 2024 Pre-market stock movers are a hot topic on Tuesday and we're diving into all of the biggest winners and losers this morning! Via InvestorPlace Arista Networks Reports Q4 Results, Joins Teradata, Lattice Semiconductor And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session February 13, 2024 U.S. stock futures were lower this morning, with the Nasdaq futures trading lower by around 100 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 12, 2024 Via Benzinga G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee February 12, 2024 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference January 08, 2024 From G1 Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session December 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 07, 2023 Via Benzinga G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy December 05, 2023 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium November 29, 2023 From G1 Therapeutics Via GlobeNewswire Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 01, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 01, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 01, 2023 Via Benzinga G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights November 01, 2023 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics’ COSELA® (trilaciclib) Recommended in Updated Small Cell Lung Cancer Guidelines from the American Society of Clinical Oncology (ASCO) October 18, 2023 From G1 Therapeutics Via GlobeNewswire Real World Data Indicate That Trilaciclib Reduces Hospitalizations and Myelosuppressive Events and May Improve Survival in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) October 27, 2023 Multiple Analyses Also Describe Significant Burden of Chemotherapy-Induced Myelosuppression and Impact on Healthcare Resource Utilization in ES-SCLC From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium October 16, 2023 From G1 Therapeutics Via GlobeNewswire Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 19, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 21, 2023 Via Benzinga Black Diamond Therapeutics Announces CEO Transition September 18, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 October 06, 2023 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.